B
Biosency
Medical device company focused on developing smart healthcare solutions
About Biosency
Biosency is a medical device company founded in 2018 and based in Cesson Sevigne, France. The company specializes in the development and commercialization of remote monitoring solutions for patients with chronic respiratory diseases.
Its main product is the Bora care® telemonitoring platform, a medical device (MD class 2a) that enables the remote monitoring of patients with respiratory failure. The platform is patient-centric and utilizes a connected photoplethysmogram (PPG) sensor to collect data. This data is then analyzed to provide real-world care management for chronic respiratory diseases. The company's business model is focused on providing these smart healthcare solutions to the telemonitoring and respiratory care sectors.
Source: Dealroom company dataAt a glance
- Founded
- 2017
- Headquarters
- Saint-Grégoire, France
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
GO Capital
Series A1 investor entered at this stage
Crédit Agricole
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biosency on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biosency on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.